🔗 Permalink

Inventor profile of:

Nick Giannoukakis

City:

Coraopolis, Pennsylvania

Country:

United States

Published Applications:

Last publication date:

2021-12-30

Top Assignees for applications by Nick Giannoukakis

The entities that hold a legal rights for patent applications filed by inventor Giannoukakis Nick:

UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 10 Pittsburgh, PA United States
BAXTER INTERNATIONAL INC. 4 Deerfield, IL United States
Baxter Healthcare S.A. 3 Wallisellen, Switzerland
BAXTER HEALTHCARE S.A. 2 Glattpark (Opfikon), Switzerland
Duquesne University 1 Pittsburgh, PA United States

Recent patent applications by Giannoukakis Nick

Nick Giannoukakis from Coraopolis, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-12-30

US20210401884A1

Human necessities

MICROSPHERE-BASED DELIVERY AND EX VIVO MANIPULATION OF DENDRITIC CELLS FOR AUTOIMMUNE THERAPIES

#2 | 2019-10-24

US20190321398A1

Human necessities

Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies

#3 | 2017-12-21

US20170360834A1

Human necessities

Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies

#4 | 2016-11-24

US20160338984A1

Human necessities

Particle formulations of all-trans retinoic acid and transforming growth factor beta for the treatment of type 1 diabetes mellitus

#5 | 2016-08-11

US20160230174A1

Chemistry; metallurgy

TOLEROGENIC DENDRITIC CELLS TO TREAT INFLAMMATORY BOWEL DISEASE

#6 | 2015-05-21

US20150139965A1

Human necessities

Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies

#7 | 2012-06-07

US20120141549A1

Chemistry; metallurgy

OLIGONUCLEOTIDES TARGETING ASTHMA INFLAMMATION PROCESSES

#8 | 2011-11-10

US20110274758A1

Human necessities

Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes

#9 | 2010-10-14

US20100260855A1

Chemistry; metallurgy

Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes

#10 | 2009-11-26

US20090291145A1

Chemistry; metallurgy

Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes

#11 | 2008-02-14

US20080039369A1

Human necessities

Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes

InventorID:

1167524 ⎘